Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4315)
All Articles published online
|
Sep 28, 2009 (publication date) through Dec 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sun H, Ren J, Zhu Q, Kong FZ, Wu L, Pan BR. Effects of lysophosphatidic acid on human colon cancer cells and its mechanisms of action. World J Gastroenterol 2009; 15(36): 4547-4555 [PMID: 19777613 DOI: 10.3748/wjg.15.4547] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i36/4547.htm |
| Number | Citing Articles |
| 1 |
Xiusheng Zhu, Lanyu Li, Bangjun Gao, Dandan Zhang, Yanyan Ren, Beibei Zheng, Mengmei Li, Deshun Shi, Ben Huang. Early development of porcine parthenogenetic embryos and reduced expression of primed pluripotent marker genes under the effect of lysophosphatidic acid. Reproduction in Domestic Animals 2018; 53(5): 1191 doi: 10.1111/rda.13226
|
| 2 |
Si Liu, Haiyan Jiang, Li Min, Tingting Ning, Junxuan Xu, Tiange Wang, Xingyu Wang, Qian Zhang, Ruizhen Cao, Shutian Zhang, Shengtao Zhu. Lysophosphatidic acid mediated PI3K/Akt activation contributed to esophageal squamous cell cancer progression. Carcinogenesis 2021; 42(4): 611 doi: 10.1093/carcin/bgaa143
|
| 3 |
Renata de Freitas Saito, Luciana Nogueira de Sousa Andrade, Silvina Odete Bustos, Roger Chammas. Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.768606
|
| 4 |
Metabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipids. Journal of Lipid Research 2012; 53(8): 1610 doi: 10.1194/jlr.M027185
|
| 5 |
Gizem E. Genc, Victoria E.B. Hipolito, Roberto J. Botelho, Saadet Gumuslu. Lysophosphatidic acid represses autophagy in prostate carcinoma cells. Biochemistry and Cell Biology 2019; 97(4): 387 doi: 10.1139/bcb-2018-0164
|
| 6 |
|
| 7 |
Matteo Centonze, Giusy Di Conza, Michael Lahn, Isabel Fabregat, Francesco Dituri, Isabella Gigante, Grazia Serino, Rosanna Scialpi, Livianna Carrieri, Roberto Negro, Elena Pizzuto, Gianluigi Giannelli. Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models. Journal of Experimental & Clinical Cancer Research 2023; 42(1) doi: 10.1186/s13046-023-02780-4
|
| 8 |
Daphna Mokady, David Meiri. RhoGTPases – A novel link between cytoskeleton organization and cisplatin resistance. Drug Resistance Updates 2015; 19: 22 doi: 10.1016/j.drup.2015.01.001
|
| 9 |
Nasser Samadi, Raie Bekele, Dora Capatos, Ganesh Venkatraman, Meltem Sariahmetoglu, David N. Brindley. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance. Biochimie 2011; 93(1): 61 doi: 10.1016/j.biochi.2010.08.002
|
| 10 |
Ji-yuan Sun. GPCR-CARMA3-NF-kappaB signaling axis: A novel drug target for cancer therapy. Clinical Oncology and Cancer Research 2010; 7(3): 159 doi: 10.1007/s11805-010-0512-1
|
| 11 |
Derya Isler, Mehmet Ozaslan, Isik Didem Karagoz, Ibrahim Halil Kilic, Metin Karakok, Seyithan Taysi, Izzettin Guler, Ahmet Cakmak, Abdullah Tuncay Demiryurek. Antitumoral effect of a selective Rho-kinase inhibitor Y-27632 against Ehrlich ascites carcinoma in mice. Pharmacological Reports 2014; 66(1): 114 doi: 10.1016/j.pharep.2013.06.006
|
| 12 |
A. Kuksis, Y. Itabashi, W. Pruzanski. Encyclopedia of Lipidomics. 2016; : 1 doi: 10.1007/978-94-007-7864-1_163-1
|
| 13 |
Donghee Kim, Hyo-Jin Kim, Jin-Ok Baek, Joo-Young Roh, Hee-Sook Jun. Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway. International Journal of Molecular Sciences 2021; 22(19): 10777 doi: 10.3390/ijms221910777
|
| 14 |
Mariana Ramos Gonzaga, Sofia Xavier Silva, Giovana Diniz Jorge, Alessandro Furtado Silva. Ácido Lisofosfatídico: alvo promissor para novas terapêuticas no Câncer Colorretal. Cuadernos de Educación y Desarrollo 2024; 16(12 Edição Especial): e6538 doi: 10.55905/cuadv16n12-063
|
| 15 |
Dongjun Lee, Dong-Soo Suh, Sue Chin Lee, Gabor J. Tigyi, Jae Ho Kim. Role of autotaxin in cancer stem cells. Cancer and Metastasis Reviews 2018; 37(2-3): 509 doi: 10.1007/s10555-018-9745-x
|
| 16 |
Ingun Heiene Tveteraas, Monica Aasrum, Ingvild Johnsen Brusevold, John Ødegård, Thoralf Christoffersen, Dagny Sandnes. Lysophosphatidic acid induces both EGFR-dependent and EGFR-independent effects on DNA synthesis and migration in pancreatic and colorectal carcinoma cells. Tumor Biology 2016; 37(2): 2519 doi: 10.1007/s13277-015-4010-1
|
| 17 |
Ming Quan, Jiu-jie Cui, Xiao Feng, Qian Huang. The critical role and potential target of the autotaxin/lysophosphatidate axis in pancreatic cancer. Tumor Biology 2017; 39(3): 101042831769454 doi: 10.1177/1010428317694544
|
| 18 |
Yan Liao, Ganggang Mu, Lingli Zhang, Wei Zhou, Jun Zhang, Honggang Yu. Lysophosphatidic Acid Stimulates Activation of Focal Adhesion Kinase and Paxillin and Promotes Cell Motility, via LPA1–3, in Human Pancreatic Cancer. Digestive Diseases and Sciences 2013; 58(12): 3524 doi: 10.1007/s10620-013-2878-4
|
| 19 |
Ondřej Vít, Jiří Petrák. Autotaxin and Lysophosphatidic Acid Signalling: the Pleiotropic Regulatory Network in Cancer. Folia Biologica 2023; 69(5-6): 149 doi: 10.14712/fb2023069050149
|
| 20 |
Xiaoyun Tang, Matthew G.K. Benesch, David N. Brindley. Role of the autotaxin–lysophosphatidate axis in the development of resistance to cancer therapy. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(8): 158716 doi: 10.1016/j.bbalip.2020.158716
|
| 21 |
Nan Sethakorn, Nickolai O. Dulin. RGS expression in cancer: oncomining the cancer microarray data. Journal of Receptors and Signal Transduction 2013; 33(3): 166 doi: 10.3109/10799893.2013.773450
|
| 22 |
Fernanda Leve, Taline Guimarães Corrêa Marcondes, Lilian Gonçalves R. Bastos, Sarah Vieira Rabello, Marcelo Neves Tanaka, José Andrés Morgado-Díaz. Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA–Rock and Src–FAK signalling in colon cancer cells. European Journal of Pharmacology 2011; 671(1-3): 7 doi: 10.1016/j.ejphar.2011.09.006
|
| 23 |
Tamotsu Tsukahara, Kimiko Murakami-Murofushi. Release of Cyclic Phosphatidic Acid from Gelatin-based Hydrogels Inhibit Colon Cancer Cell Growth and Migration. Scientific Reports 2012; 2(1) doi: 10.1038/srep00687
|
| 24 |
Lianqing Lou, Yong Xin Chen, Lingzhen Jin, Xiaofei Li, Xingfei Tao, Jinhong Zhu, Xiangyi Chen, Shuang Wu, Weiwei Ye, Jinke He, Guoqiang Ding. Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor. Journal of International Medical Research 2013; 41(1): 55 doi: 10.1177/0300060512474124
|
| 25 |
Jiyuan Sun. CARMA3: A novel scaffold protein in regulation of NF-κB activation and diseases. World Journal of Biological Chemistry 2010; 1(12): 353-361 doi: 10.4331/wjbc.v1.i12.353
|
| 26 |
Silvia Anahi Valdés-Rives, Aliesha González-Arenas. Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development. Mediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/9173090
|
| 27 |
Anna Jesionowska, Elzbieta Cecerska-Heryc, Natalia Matoszka, Barbara Dolegowska. Lysophosphatidic acid signaling in ovarian cancer. Journal of Receptors and Signal Transduction 2015; 35(6): 578 doi: 10.3109/10799893.2015.1026444
|